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Chronotype represents an individual’s preferred time of day to perform daily activities. Late chronotypes 
(i.e. “evening people”) tend to have higher risk for obesity, hypertension and type 2 diabetes than 
morning chronotypes. However, to what extent insulin sensitivity or central hemodynamics relates to 
chronic disease risk per chronotype remains unclear in people with metabolic syndrome (MetS). 
PURPOSE: To understand whether chronotype has relationships with insulin sensitivity and central 
hemodynamics in patients with MetS. METHODS: Chronotype was defined by self-reported Morning-
Eveningness Questionnaire (MEQ) of 39 adults with MetS (median age 54 yr, 36 kg/m2 BMI, 3 ATP III 
criteria, 82.1% Female) per ATP III criteria. Population was divided at the 50% to compare morning 
(n=20) versus evening (n=19) chronotype. The Epworth questionnaire was provided to determine 
daytime sleepiness. A 120 min euglycemic clamp (40 mU/m2/min, 90 mg/dl) was performed to test 
metabolic insulin sensitivity (glucose infusion rate). Central hemodynamics were characterized 
(augmentation index (AIx75bpm), augmentation pressure (AP), forward (Pf) and backward (Pb) pulse 
wave, pulse pressure (PP)) before and after the clamp. VO2peak (indirect calorimetry) and body 
composition (DEXA) were also measured. RESULTS: There was no difference in age, BMI, ATP III 
criteria or daytime sleepiness between groups. Morning chronotype though tended to have higher VO2peak 
(ml/kg/min) (p=0.09) and metabolic insulin sensitivity (p=0.065), as well as lower AIx75  (p=0.09), AP  
(p=0.054), and Pf (p=0.06) after insulin infusion than evening chronotype. MEQ was significantly linked 
to fasting glucose (r= -0.32, p=0.04), HDL (r= -0.34, p=0.03) and Pf 120 min (p=0.058, r=-0.32). BMI 
was also significantly correlated with AP (r= 0.32, p=0.054), PP (r= 0.44, p= 0.007) and Pb (r=0.45, p= 
0.006) and Pf (r=0.39, p=0.02) 120 min after insulin infusion. CONCLUSIONS: Despite classification 
of MetS, morning chronotype appears to confer more favorable cardiometabolic health than self-
identified “evening people”.   
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